New
Trackinsight Enterprise, a unified platform for institutional ETF research, analytics, and compliance, is now live. Explore Trackinsight Enterprise →
Help us improve your experience. Please confirm your investor type:
Compare ETFs Easily
The Ultimate ETF Comparison Tool - Try Now!
Analyze up to 5 ETFs side-by-side and gain instant insights on performance, fees, holdings, and more to make data-driven investment decisions.
IBBQ ETF · Invesco Nasdaq Biotechnology ETF
The IBBQ Exchange Traded Fund (ETF) is provided by Invesco. It is built to track an index: NASDAQ Biotechnology Index. The IBBQ ETF provides physical exposure, so by buying it you actually own parts of all the 262 underlying holdings. This share class generates a stream of income by distributing dividends.
Last update Yesterday at 1:30 PM UTC
LIVE
CLOSED
This fund is part ofUS Health Care1M perf.-3.88%
Last price
$28.46
1M perf.
-1.87%
1M flows
N/A
AuM
€63M
E/R
0.19%
Rating
Not rated
ESG Consensus®
IBBQ
$28.46
Performance & flows
Segment for quartile rank
December 12, 2025 → March 12, 2026
Create a free account to view the flows graph
IBBQ
$28.59
+0.72%
US Health Care
-2.59%
Historic performance and flows
| 1M | 3M | 1Y | 3Y | 5Y | MTD | QTD | YTD | ||
|---|---|---|---|---|---|---|---|---|---|
| Perf. | -1.87%  | +0.72% | +29.85% | +46.86% | N/A | -4.87% | +0.75% | +0.75% | |
| Flows |
Key fund info
Segment for quartile rank
This ETF's jurisdiction country is not in your region (Europe and Middle East) ·
Main characteristics
Issuer
CUSIP
46138G599
ISIN
US46138G5999
AuM
€63M
E/R
0.19%
Replication rating
Not rated
ESG Consensus®
More details
NAV
3/12/2026
$28.59
1D NAV change
-2.69%
Dividend policy
Replication method
Direct (Physical)
Replication model
Full replication
No. of holdings
262
Inception date
6/9/2021
Jurisdiction
United States
Distribution
United States
Legal structure
Open-end Investment Company
Base currency
USD
Dividend distribution
Trailing 12-month distr. yield
Distribution frequency
Last distribution
Create a free account to view dividend distribution
Classification
Investment strategy
The Invesco Nasdaq Biotechnology ETF (Fund) is based on the Nasdaq Biotechnology Index (Index). The Fund will normally invest at least 90% of its total assets in the securities that comprise the Index. The Index is designed to measure the performance of securities listed on the Nasdaq Stock Market that are classified as either biotechnology or pharmaceutical companies. The Fund and the Index are reconstituted annually in December and rebalanced quarterly in March, June, September and December.
Tax optimisation
PEA
France
UK Reporting Status
United Kingdom
Create a free Trackinsight Essentials account to unlock insights
Access exclusive metrics and features to support your investment decisions.
Built for professionals: access exclusive fund metrics and selection tools in Trackinsight Enterprise.
Enterprise Fund page features include:
Legal documents
Powerful buy-list integration
Fund data exports
Advanced risk metrics
Advanced replication analysis
Advanced exposure look-through
Upload your own internal metrics
Custom data feature
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseSimilar ETFs in your region
BTEC
1M perf.
-1.90%
E/R
0.35%
203780
1M perf.
+1.98%
E/R
0.3%
00678
1M perf.
+0.59%
E/R
1.01%
IBB
1M perf.
-2.61%
E/R
0.44%
HTEC
1M perf.
-4.76%
E/R
0.8%
Advertisement
Risk profile
Segment for quartile rank
Historical risk/return profile
| 3M | 1Y | 3Y | 5Y | |
|---|---|---|---|---|
| Returns | +0.72% | +29.85% | +46.86% | N/A |
| Volatility | ||||
| Perf./Volatility | ||||
| Max drawdown |
Create a free account to view risk/return table
Synthetic Risk and Reward Indicator (SRRI)
UCITS
N/A
PRIIPS
N/A
Built for professionals: access exclusive risk metrics in Trackinsight Enterprise.
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseExposure
Countries
USA
93.84%
United Kingdom
1.44%
Ireland
1.28%
Bermuda
1.18%
Other
2.25%
Sectors
Health Care
85.82%
Unavailable
14.16%
Diversification
Total weight of top 15 holdings out of 262
Top 15 holdings
Data as of January 31, 2026
VERTEX PHARMACEUTICALS
GILEAD SCIENCES
AMGEN-T
REGENERON PHARMACEUTICALS
ALNYLAM PHARMACEUTICALS
INSMED
BIOGEN INC
US04016X1019
Create a free account to view top holdings
ILLUMINA
UTD THERAPEUT
INCYTE
REVOLUTION MEDICINES INC
MODERNA INC
ROYALTY PHARMA
MEDPACE HOLDINGS INC
Create a free account to view top holdings
Built for professionals: access exclusive exposure metrics in Trackinsight Enterprise.
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseSustainability
Integrates ESG criteria
No
SDG
ESG Consensus® by Conser
Data as of December 31, 2025
MethodologyOur partner Conser gathers the industry's consensus on the business practices of the underlying holdings. We have computed the following metrics about IBBQ ETF's sustainability, based on their methodology.
ESG Consensus®
ESG Consensus® is based on the Final Sustainability Grade, which itself consists of 10 grades. Our partner Conser calculates the exact grade, based on market intelligence, using their proprietary ESG Consensus® methodology.
IBBQ’s has a Final Sustainability Grade of either B+, B, or B-.
A+
A
A-
B+
B
B-
C+
C
C-
D
This fund’s exact Final Sustainability Grade is available in Trackinsight Enterprise.
Learn more about Trackinsight EnterpriseHoldings review
89.58% of holdings have positive scoring
10.43% of holdings have negative scoring
5.62%
62.62%
21.34%
6.09%
Consensus levels
Strong
Medium
Weak
Built for professionals: access exclusive sustainability metrics in Trackinsight Enterprise.
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseReplication
Trackinsight replication rating:
Not rated
Replication quality
Calculated over 12m, as of February 27, 2026
Tracking error
Tracking difference
Replication information
Index
NASDAQ Biotechnology Index - USD
Index ticker
NBI Index
Index dividend policy
PI
Replication method
Replication model
Built for professionals: access exclusive replication metrics in Trackinsight Enterprise.
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseIssuer
Invesco
Invesco ID Card
Number of funds
631
Total AuM
€849.23B
Expense ratio range
0.04% - 5.39%
Average expense ratio
0.3562%
Top 5 funds by Invesco
| AuM | ||
|---|---|---|
QQQ | Invesco QQQ ETF | €335.71B |
RSP | Invesco S&P 500® Equal Weight ETF | €73.73B |
QQQM | Invesco NASDAQ 100 ETF | €60.94B |
SPXS | Invesco S&P 500 UCITS ETF | €30.51B |
SGLD | Invesco Physical Gold USD ETC | €28.5B |
Frequently asked questions about IBBQ
What does Invesco Nasdaq Biotechnology ETF, IBBQ, invest in?
IBBQ is a Passive ETF. This ETF provides exposure to US Equities.
Which benchmark or index does IBBQ replicate?
IBBQ tracks the NASDAQ Biotechnology Index - USD, through a full replication replication method.
What is the Total Expense ratio (TER) of IBBQ?
IBBQ carries a total expense ratio (TER) of 0.19%, indicating the annual cost for holding the fund.
When was IBBQ launched?
IBBQ was introduced to the market on June 9, 2021. It trades on United States
Who is the ETF issuer of IBBQ?
Invesco Nasdaq Biotechnology ETF, IBBQ, is provided by Invesco. Learn more about Invesco here.
What is the current assets under management (AUM) of IBBQ?
IBBQ oversees €63M in assets as of March 12, 2026.
How has IBBQ performed lately?
Based on data from March 12, 2026, IBBQ returned -1.87% over the past month, 0.72% over the last three months and 0.75% year-to-date.
What are the latest inflows or outflows for IBBQ?
As of March 12, 2026, IBBQ recorded net flows of +€6.8M year-to-date.
Does IBBQ distribute dividends?
IBBQ follows a distributing dividend policy, meaning it pays out income to investors. As of March 12, 2026, its 12-month trailing yield was 0.89%.
What are the main country or region exposures of IBBQ?
As of January 31, 2026, IBBQ has significant geographic allocations in USA, United Kingdom and Ireland.
In which sector or theme does IBBQ invest in?
As of January 31, 2026, IBBQ focuses largely on Health Care.
How many securities does IBBQ hold and how diversified is it?
As of January 31, 2026, IBBQ holds 262 positions in its portfolio, with 52.08% of assets concentrated in its top 15 holdings.
What are the main positions in IBBQ?
As of January 31, 2026, IBBQ top three holdings include VERTEX PHARMACEUTICALS, GILEAD SCIENCES and AMGEN-T.
What is the base currency of IBBQ?
The base currency of IBBQ is USD.
Advertisement
About Trackinsight
Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.
Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.
In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.
This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.
Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.
More about TrackinsightETF TOOLS
PLATFORM
ETF NEWS & RESEARCH
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy | Cookie policy | | Terms of use | Imprint
Privacy policy | Cookie policy | | Terms of use | Imprint
